A5017654811- Coronary Interventions and Diagnostics
- Cardiac Valve Diseases and Treatments
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Tissue Engineering and Regenerative Medicine
- Cardiac Structural Anomalies and Repair
- Colorectal Cancer Surgical Treatments
- Parallel Computing and Optimization Techniques
- Numerical Methods and Algorithms
- Atherosclerosis and Cardiovascular Diseases
- Orthopaedic implants and arthroplasty
- Polynomial and algebraic computation
- Matrix Theory and Algorithms
- Cardiac pacing and defibrillation studies
- Cardiac and Coronary Surgery Techniques
- Medical Imaging Techniques and Applications
- Healthcare Systems and Public Health
- Pain Management and Treatment
- Cellular Automata and Applications
- Blood Pressure and Hypertension Studies
- Cardiac electrophysiology and arrhythmias
- Magnesium Alloys: Properties and Applications
- Medical and Biological Ozone Research
Ospedale di Sanremo
2013-2024
Ospedale di Rivoli
2023
Ospedale Santa Corona
2023
University of Genoa
2002
University of Foggia
2001
University of Pisa
1991
Istituto di Matematica Applicata e Tecnologie Informatiche
1989
We studied the role of telecardiology in reducing unnecessary hospital admissions patients with suspected life-threatening cardiac events (CEs), evaluated by general practitioners (GPs). Over one month, 456 consecutive (mean age 65 years, SD 19) complaining typical (10%) or atypical (42%) chest pain, palpitations (19%), dyspnoea (19%) syncope were enrolled. Before teleconsultation, GPs recorded their own opinion (based on clinical evaluation only) about presence a CE. Following transmission...
Objectives To assess the feasibility and clinical results following a prespecified bioresorbable vascular scaffold (Absorb BVS) implantation strategy in ST-elevation myocardial infarction (STEMI) patients. Backgrounds Concerns raised about BVS safety STEMI setting because not negligible thrombosis rate was reported within 30 days 12 months after implantation. Technical procedural issues related to structural features were advocated as probable causes for thrombotic events. Methods This is an...
To date, very little is known about the performance of a sirolimus-eluting bioresorbable magnesium scaffold (Mg-BRS) in patients with acute myocardial infarction (AMI). A multicenter cohort analysis was performed on 69 consecutive AMI subjects treated Mg-BRS. Procedural success obtained all cases, and no in-hospital events were reported. At 9-month follow-up, cardiac death, target-vessel infarction, ischemia-driven target lesion revascularization, or Mg-BRS thrombosis Although our showed...
Abstract Background Little is known about intraprocedural and mid–term results of intravascular lithotripsy (IVL) use in patients with acute MI. Methods In Our retrospective analysis, data from 21 Centers Italy Spain between January 2020 November 2021 were collected. Patients allocated to the AMI–group when IVL was performed during an Primary safety endpoint defined as freedom major adverse cardiac events (MACE: death, myocardial infarction (MI), target vessel revascularization (TLR) or...